Table 3.
The mean ± standard deviation of DAT binding potentials in total striatum and in subregions of the striatum from RLS and Control subjects during day and night assessments
| ST | aPU | pPU | aCN | pCN | VS | |
|---|---|---|---|---|---|---|
| Control–Day (N = 20) | 1.65 ± 0.16 | 1.83 ± 0.21 | 1.84 ± 0.16 | 1.65 ± 0.18 | 1.06 ± 0.21 | 1.13 ± 0.28 |
| RLS-Day (N = 20) | 1.43 ± 0.19 | 1.65 ± 0.22 | 1.61 ± 0.22 | 1.44 ± 0.27 | 0.95 ± 0.27 | 1.07 ± 0.24 |
| ANOVA | F = 11.9 | F = 6.0 | F = 10.5 | F = 6.7 | F = 0.68 | F = 0.36 |
| P = 0.0015 | P = 0.020 | P = 0.0026 | P = 0.014 | P = 0.42 | P = 0.55 | |
| Control-Night (N = 14) | 1.66 ± 0.16 | 1.80 ± 0.17 | 1.87 ± 0.15 | 1.66 ± 0.21 | 1.16 ± 0.17 | 1.12 ± 0.25 |
| RLS-Night (N = 16) | 1.43 ± 0.19 | 1.58 ± 0.19 | 1.56 ± 0.21 | 1.41 ± 0.24 | 0.93 ± 0.25 | 1.03 ± 0.27 |
| ANOVA | F = 12.4 | F = 10.5 | F = 20.6 | F = 9.71 | F = 7.98 | F = 0.96 |
| P = 0.0015 | P = 0.0031 | P = 0.0001 | P = 0.0042 | P = 0.0086 | P = 0.34 | |
| All Control vs All RLS | F = 27.4 | F = 16.7 | F = 34.5 | F = 17.8 | F = 8.9 | F = 1.6 |
| P < 0.0001 | P = 0.0001 | P < 0.0001 | P < 0.0001 | P = 0.004 | P = 0.2 | |
| Day vs Night | F = 0.035 | F = 1.08 | F = 0.05 | F = 0.03 | F = 0.48 | F = 0.12 |
| P = 0.85 | P = 0.3 | P = 0.8 | P = 0.9 | P = 0.5 | P = 0.7 | |
| Interaction | F = 0.013 | F = 0.05 | F = 0.39 | F = 0.21 | F = 1.07 | F = 0.05 |
| P = 0.91 | P = 0.8 | P = 0.8 | P = 0.7 | P = 0.3 | P = 0.8 | |
ST, total striatum; aPU, anterior putamen; pPu, posterior putamen; aCN, anterior caudate nucleus; pCN, posterior caudate nucleus; VS, ventral striatum.